These results provide direct confirmation of the hypothesis that indirect display of tumor-specific antigens on tumor-infiltrating APCs is sufficient for CD4+ T cells-mediated tumor rejection [10, 13, 20]. This evidence concerns the gene CD4 and neoplasm.